Recommendations for the use of DMARDs in pregnancy and reproductive health for patients with rheumatic disease: A scoping review

医学 阿达木单抗 英夫利昔单抗 Golimumab公司 阿巴塔克普 阿纳基纳 依那西普 类风湿性关节炎 托法替尼 内科学 怀孕 托珠单抗 强直性脊柱炎 磺胺吡啶 羟基氯喹 物理疗法 美罗华 重症监护医学 疾病 生物 遗传学 2019年冠状病毒病(COVID-19) 淋巴瘤 溃疡性结肠炎 传染病(医学专业)
作者
Athena Chin,Alice Terrett,Mi‐Hye Kwon,Samuel Whittle,Catherine Hill
出处
期刊:Arthritis Care and Research [Wiley]
标识
DOI:10.1002/acr.25558
摘要

Objective Autoimmune rheumatic diseases commonly affect individuals of childbearing age, with historically increased adverse pregnancy outcomes in this group. The advent of disease‐modifying anti‐rheumatic drugs (DMARDs) has fostered more suitable conditions for pregnancy; however, this is accompanied by challenges in ensuring safe use in reproductive health. The aim of this review is to compare existing guideline recommendations for the use of DMARDs in pregnancy and reproductive health for patients with rheumatic disease. Methods A scoping review was performed with Medline and EMBASE, in addition to a hand search, to identify guidelines published since 2014 by academic societies in rheumatology that addressed management of DMARDs in pregnancy in any of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus. Conventional synthetic DMARDs (csDMARDS; methotrexate, sulfasalazine, leflunomide, hydroxychloroquine), biologic DMARDs (bDMARDs; adalimumab, etanercept, infliximab, golimumab, certolizumab, abatacept, tocilizumab, rituximab, anakinra) and targeted synthetic DMARDs (tsDMARDs; tofacitinib, baricitinib, upadacitinib) were targeted. Two authors performed data extraction in duplicate. Results 18 guidelines were included. Recommendations for DMARD use in pre‐conception were present in 10 (56%), lactation in 12 (67%) and male fertility in 6 (33%). 13 (72%) guidelines included recommendations for csDMARDs, 13 (72%) bDMARDs and 5 (28%) tsDMARDs. There was moderate evidence supporting relatively uniform csDMARD recommendations, compared to minimal evidence for b/tsDMARD use with variable recommendations. Conclusion There is heterogeneity in formulation of guidelines on the use of DMARDs in pregnancy. Recommendations for csDMARDs were similar between guidelines. There was significant variability in recommendations for b/tsDMARD use, reflecting current minimal literature in this area.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6应助srandrs采纳,获得10
刚刚
小二郎应助小酒很努力吖采纳,获得10
刚刚
刚刚
1秒前
1秒前
2秒前
小二郎应助迅速的晟睿采纳,获得10
2秒前
星辰大海应助山君采纳,获得10
4秒前
Wang1991发布了新的文献求助10
5秒前
back you up发布了新的文献求助10
5秒前
所所应助xiaxiao采纳,获得20
5秒前
5秒前
Aaron发布了新的文献求助10
5秒前
缥缈的松鼠完成签到 ,获得积分10
6秒前
wanhe发布了新的文献求助10
6秒前
罗文靓完成签到,获得积分10
7秒前
酷波er应助优雅不愁采纳,获得10
7秒前
7秒前
Ava应助自觉白开水采纳,获得10
8秒前
8秒前
挖掘机应助sophyw采纳,获得200
10秒前
10秒前
11秒前
11秒前
wanhe完成签到,获得积分10
12秒前
12秒前
怕孤单的迎天应助芋头采纳,获得10
12秒前
my发布了新的文献求助30
12秒前
ouyangshi发布了新的文献求助10
13秒前
专注之槐完成签到,获得积分10
13秒前
13秒前
WL发布了新的文献求助10
13秒前
14秒前
AprilLeung发布了新的文献求助10
14秒前
Mercury完成签到,获得积分20
14秒前
马小跳完成签到 ,获得积分10
14秒前
刘亚虓完成签到,获得积分10
15秒前
静心发布了新的文献求助10
15秒前
SciGPT应助zxm采纳,获得10
16秒前
拼搏一曲发布了新的文献求助10
16秒前
高分求助中
(禁止应助)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Plutonium Handbook 4000
International Code of Nomenclature for algae, fungi, and plants (Madrid Code) (Regnum Vegetabile) 1500
Functional High Entropy Alloys and Compounds 1000
Building Quantum Computers 1000
Molecular Cloning: A Laboratory Manual (Fourth Edition) 500
Social Epistemology: The Niches for Knowledge and Ignorance 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4232724
求助须知:如何正确求助?哪些是违规求助? 3766059
关于积分的说明 11832964
捐赠科研通 3424638
什么是DOI,文献DOI怎么找? 1879415
邀请新用户注册赠送积分活动 932281
科研通“疑难数据库(出版商)”最低求助积分说明 839512